AAA Endografts Show Early Promise In Lowering Mortality – Lancet Study
This article was originally published in The Gray Sheet
Executive Summary
Longer-term follow-up is needed to confirm early clinical results showing a survival benefit for patients receiving endovascular aneurysm repair versus open surgery for abdominal aortic aneurysm treatment, according to an Aug. 25 Lancet study
You may also be interested in...
U.K. Studies: No Lasting Mortality Benefit For Endovascular AAA Repair
Results of two United Kingdom-based studies of abdominal aortic aneurysm repair conclude endovascular stent grafts are not associated with lower long-term mortality and death rates compared with surgical repair or no intervention
U.K. Studies: No Lasting Mortality Benefit For Endovascular AAA Repair
Results of two United Kingdom-based studies of abdominal aortic aneurysm repair conclude endovascular stent grafts are not associated with lower long-term mortality and death rates compared with surgical repair or no intervention
Long-Term Data On Medtronic AAA Graft Prompts FDA Public Health Notice
FDA says that new long-term data shows that the aneurysm-related mortality in patients treated with Medtronic's AneuRx abdominal aortic aneurysm (AAA) graft is "substantially higher" than the mortality rate for open surgical repair